Physician profile
Jonathan Gamss
NPI 1598922874
$1,515.43
in general payments reported to CMS, 2019-2025
17 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $31.61 · 2021: $140 · 2022: $333 · 2023: $249 · 2024: $441 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $629.64 | 2021-2025 | |
| Novo Nordisk INC | $138.06 | 2022-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $134.47 | 2019-2024 | Andexxa, Fasenra |
| Regeneron Healthcare Solutions, INC. | $124.83 | 2022 | |
| Janssen Pharmaceuticals, INC | $92.73 | 2019-2024 | Xarelto |
| Gilead Sciences, INC. | $56.75 | 2022-2023 | |
| Csl Behring | $49.00 | 2023-2025 | Kcentra |
| Pfizer INC. | $47.88 | 2019-2025 | |
| Allergan, INC. | $47.62 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.32 | 2019-2023 | Jardiance |
| Meridian Bioscience INC. | $38.42 | 2023 | |
| Vapotherm INC | $29.73 | 2019 | |
| Bioxcel Therapeutics, INC. | $21.97 | 2023 | Igalmi |
| Inari Medical, INC. | $20.00 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alexion Pharmaceuticals, INC. | $16.48 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $14.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gamss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.